Nautilus Biotechnology, Inc.
NAUT
$1.70
-$0.15-8.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -8.28% | 2.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.27% | -5.69% | |||
| Operating Income | 9.27% | 5.69% | |||
| Income Before Tax | 9.51% | 5.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 9.51% | 5.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.51% | 5.58% | |||
| EBIT | 9.27% | 5.69% | |||
| EBITDA | 9.46% | 5.98% | |||
| EPS Basic | 9.57% | 5.86% | |||
| Normalized Basic EPS | 9.60% | 18.76% | |||
| EPS Diluted | 9.57% | 5.86% | |||
| Normalized Diluted EPS | 9.60% | 18.76% | |||
| Average Basic Shares Outstanding | 0.05% | 0.28% | |||
| Average Diluted Shares Outstanding | 0.05% | 0.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||